MedTrace Logo

New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes

NCT06948851 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2025-04-29

No results posted yet for this study

Summary

Epiretinal membranes (ERM) are a macular disorder leading to metamorphopsia and a decrease in visual acuity. Peeling of ERM during vitrectomy is, up to date, the only possible treatment option, opening chances for improvements of visual acuity and metamorphopsia. Occurrence of new intraretinal cystoid changes was described to be associated with a lower level of visual acuity after surgery, compared to patients, that never had intraretinal cystoid changes Aim of our study was to analyze development of new intraretinal cystoid changes after vitrectomy with membrane peeling with respect to postsurgical treatment strategies.

Conditions

  • Epiretinal Membrane

Sponsors & Collaborators

  • Prim. Prof. Dr. Oliver Findl, MBA

    lead OTHER

Principal Investigators

  • Christoph Leisser, MD · Vienna Institute for Research in Ocular Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06948851 on ClinicalTrials.gov